New studies show that there is no such thing as "pure" European—or anyone else. Almost all of us are the children of repeated ancient migrations, according to researchers who study ancient human origins. Indigenous Europeans, for example, descend from at least three major migrations in the past 15,000 years, including two from the Middle East. Those migrants swept across Europe, mingled with previous immigrants, and then remixed to create the peoples of today. Using revolutionary new methods to analyze DNA and the isotopes found in bones and teeth, scientists are exposing the tangled roots of peoples around the world, as varied as Germans, ancient Philistines, and Kashmiris. Few of us are actually the direct descendants of the ancient skeletons found in our backyards or historic homelands. Only a handful of groups today, such as Australian Aborigines, have deep bloodlines untainted by mixing with immigrants.
In this study, we report a novel mosquito-borne reassortant Orbivirus species, which we named Banna orbivirus (BAOV). The virus was isolated from a Culex tritaeniorhynchus pool collected in Xishuangbanna, Yunnan Province, China in 2007. Whole genome and phylogenetic analyses revealed that BAOV is a reassortant of several Tibet orbivirus strains. It has a double-stranded RNA genome of 19, 270 bp, containing ten segments (S1–S10) of various lengths. The 10 segments of BAOV had high nucleotide and amino acid sequence similarity with segments of either Fengkai orbivirus or Tibet orbivirus (TIBOV, XZ0906 strain). Phylogenetic analyses indicated that the novel BAOV is a reassortant derived from XZ0906 and Fengkai orbiviruses, and is a Tibet orbivirus. This is the first report of a novel genomic reassortment of Tibet orbivirus isolated in China; these findings contribute to our understanding of the diversity of orbiviruses.
Abstract: This is the first country-wide surveillance of bat-borne viruses in Kenya spanning from 2012–2015 covering sites perceived to have medium to high level bat-human interaction. The objective of this surveillance study was to apply a non-invasive approach using fresh feces to detect viruses circulating within the diverse species of Kenyan bats. We screened for both DNA and RNA viruses; specifically, astroviruses (AstVs), adenoviruses (ADVs), caliciviruses (CalVs), coronaviruses (CoVs), flaviviruses, filoviruses, paramyxoviruses (PMVs), polyomaviruses (PYVs) and rotaviruses. We used family-specific primers, amplicon sequencing and further characterization by phylogenetic analysis. Except for filoviruses, eight virus families were detected with varying distributions and positive rates across the five regions (former provinces) studied. AstVs (12.83%), CoVs (3.97%), PMV (2.4%), ADV (2.26%), PYV (1.65%), CalVs (0.29%), rotavirus (0.19%) and flavivirus (0.19%). Novel CalVs were detected in Rousettus aegyptiacus and Mops condylurus while novel Rotavirus-A-related viruses were detected in Taphozous bats and R. aegyptiacus. The two Rotavirus A (RVA) strains detected were highly related to human strains with VP6 genotypes I2 and I16. Genotype I16 has previously been assigned to human RVA-strain B10 from Kenya only, which raises public health concern, particularly considering increased human-bat interaction. Additionally, 229E-like bat CoVs were detected in samples originating from Hipposideros bats roosting in sites with high human activity. Our findings confirm the presence of diverse viruses in Kenyan bats while providing extended knowledge on bat virus distribution. The detection of viruses highly related to human strains and hence of public health concern, underscores the importance of continuous surveillance.
Type IV secretion systems (T4SSs) are large macromolecular machines that translocate protein and DNA and are involved in the pathogenesis of multiple human diseases. Here, using electron cryotomography (ECT), we report the in situ structure of the Dot/Icm type IVB secretion system (T4BSS) utilized by the human pathogen Legionella pneumophila. This is the first structure of a type IVB secretion system, and also the first structure of any T4SS in situ. While the Dot/Icm system shares almost no sequence similarity with type IVA secretion systems (T4ASSs), its overall structure is seen here to be remarkably similar to previously reported T4ASS structures (those encoded by the R388 plasmid in Escherichia coli and the cag pathogenicity island in Helicobacter pylori). This structural similarity suggests shared aspects of mechanism. However, compared to the negative‐stain reconstruction of the purified T4ASS from the R388 plasmid, the L. pneumophila Dot/Icm system is approximately twice as long and wide and exhibits several additional large densities, reflecting type‐specific elaborations and potentially better structural preservation in situ.
The vaccine has been very effective in various diseases, however, the rate of infections it prevents are still increasing and continues to resurface as time passes by.
For the first time, bacterial spores have been evaluated as vaccine vehicles. Bacillus subtilis spores displaying the tetanus toxin fragment C (TTFC) antigen were used for oral and intranasal immunization and were shown to generate mucosal and systemi
Herpes simplex virus (HSV) entry into the cells requires glycoproteins gD, gH/gL and gB, activated in a cascade fashion by conformational modifications induced by cognate receptors and intermolecular signaling. The receptors are nectin1 and HVEM (Herpes virus entry mediator) for gD, and αvβ6 or αvβ8 integrin for gH. In earlier work, insertion of a single chain antibody (scFv) to the cancer receptor HER2 (human epidermal growth factor receptor 2) in gD, or in gH, resulted in HSVs specifically retargeted to the HER2-positive cancer cells, hence in highly specific non-attenuated oncolytic agents. Here, the scFv to HER2 was inserted in gB (gBHER2). The insertion re-targeted the virus tropism to the HER2-positive cancer cells. This was unexpected since gB is known to be a fusogenic glycoprotein, not a tropism determinant. The gB-retargeted recombinant offered the possibility to investigate how HER2 mediated entry. In contrast to wt-gB, the activation of the chimeric gBHER2 did not require the activation of the gD and of gH/gL by their respective receptors. Furthermore, a soluble form of HER2 could replace the membrane-bound HER2 in mediating virus entry, hinting that HER2 acted by inducing conformational changes to the chimeric gB. This study shows that (i) gB can be modified and become the major determinant of HSV tropism; (ii) the chimeric gBHER2 bypasses the requirement for receptor-mediated activation of other essential entry glycoproteins.
This is pretty heavy duty stuff: basically, they could retarget HSV to HER2-expressing cells by including a MAb fragment to HER2 in gB, and HER2 was sufficient to mediate cell entry. Targetted therapy using HSV, here we come?!
by G9ija Dr Fred Weli, a family health expert in Port Harcourt, says Nigeria will need about 2 million doses of vaccine to fight current meningitis epidemic. Weli told the News Agency of Nigeria (NAN) in Port Harcourt on Wednesday that current 500,000 doses available in the country were grossly inadequate to fight the epidemic.…
Cancer of the oropharynx has become increasingly common: In the United States alone, the number of newly diagnosed cases has tripled over the past three decades. About 70 percent of these tumors are caused by infection with human papillomavirus (HPV) type 16.
Created using more than 10,000 images captured by a high-resolution technique, called cryo-electron microscopy, this illustration of the Zika virus reveals something like a topographic map of the infecting agent. This zoomed-in illustration shows not just the envelope that encircles the virus, but also the RNA (in yellow) that lives inside it and allows the virus to replicate.
Researchers are developing a new type of drug delivery system that could allow people to self administer vaccines without the use of needles. Ben Gruber ha
Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that now causes epidemics affecting millions of people on multiple continents. The virus has received global attention because of some of its unusual epidemiological and clinical features, including persistent infection in the male reproductive tract and sexual transmission, an ability to cross the placenta during pregnancy and infect the developing fetus to cause congenital malformations, and its association with Guillain-Barré syndrome in adults. This past year has witnessed an intensive effort by the global scientific community to understand the biology of ZIKV and to develop pathogenesis models for the rapid testing of possible countermeasures. Here, we review the recent advances in and utility and limitations of newly developed mouse and nonhuman primate models of ZIKV infection and pathogenesis.
Recent studies have declared that members of the ssDNA virus family Microviridae play an important role in multiple environments,as they have been found taking a dominant position in the human gut.The aim of this study was to analyze the overall composition of the gut virome in coronary heart disease (CHD) patients,and try to discover the potential link between the human gut virome and CHD.Viral metagenomics methods were performed to detect the viral sequences in fecal samples collected from CHD inpatients and healthy persons as controls.We present the analysis of the virome composition in these CHD patients and controls.Our data shows that the virome composition may be linked to daily living habits and the medical therapy of CHD. Virgaviridae and Microviridae were the two dominant types of viruses found in the enteric virome of CHD patients.Fourteen divergent viruses belonging to the family Microviridae were found,twelve of which were grouped into the subfamily Gokushovirinae,while the remaining two strains might represent two new subfamilies within Microviridae,according to the phylogenetic analysis.In addition,the genomic organization of these viruses has been characterized.
22532 suspected cases (22532 in Central and South America, 0 in the Caribbean, 0 in North America), 7358 confirmed cases (14 North America, 5 Caribbean, 7336 Central and South America) (7350 autochthonous transmission and 8 travel related imported cases)
Italy's health minister has taken the unusual step of criticising national broadcaster Rai's coverage of a vaccine against a cancer-causing virus, sparking a row about media freedom and misinformation. The minister, Beatrice Lorenzin, accused the team behind the popular Rai3 documentary series
Author summary HIV-infected individuals who are receiving antiretroviral therapy continue to have low but persistent amounts of virus in blood as well as high levels of immune activation. Elevated immune activation has been linked to medical complications, like heart disease. Whether activation is being driven by or driving HIV persistence is not known. To answer this question, we measured levels of HIV, inflammation and immune activation in 101 HIV-infected individuals before and during long-term antiretroviral therapy. We found that pre-treatment levels of HIV correlated with on-treatment measures of HIV persistence. HIV levels correlated with inflammation and activation before starting therapy but not during long-term treatment, suggesting that virus persistence is not driving or driven by immune activation or inflammation. Higher levels of activation and inflammation before therapy were associated with higher levels during treatment, indicating that immune events that occurred before treatment initiation had long-lasting effects despite sustained control of the virus. These findings should stimulate studies of genetic or viral factors that affect levels of virus, activation and inflammation prior to treatment, and should inform the design of strategies to reduce HIV persistence and dampen harmful immune activation and inflammation in people who are on long-term treatment.
Special Collection on "The airborne microbiome - implications for aerosol transmission and infection control" - soliciting submissions
Many infectious diseases, such as tuberculosis, whooping cough, Aspergillus and other fungal infections, human and avian influenza, measles, chickenpox, and some of the emerging viruses, such as Middle East Respiratory Syndrome coronavirus (MERS-CoV) can be potentially spread through aerosol transmission. With the advent of deep-sequencing technologies these can be applied to environmental air samples using metagenomic techniques to characterise the presence and variety of airborne pathogens in the everyday air that we breathe in different environments (hospitals, clinics, homes, offices, entertainment venues, public transport - buses, trains, planes, etc.). This series aims to explore and characterise the airborne microbiome in different environments, using different methods, in order to understand and assess the risk that such airborne pathogens may pose to both vulnerable and otherwise healthy individuals, and explore possible interventions to control their transmission. We welcome submission of research articles and opinion pieces focused on the airborne microbiome in relation to infectious diseases.
ATLANTA, GA - (NewMediaWire) - April 03, 2017 - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today it ha
Death from flu is generally uncommon, but new U.S. research has found that when children do die of the flu, it is likely that they have not been vaccinated.
Fever 7–10 days after first dose of a measles containing vaccines occurs commonly. This study found that predictors of fever after measles vaccine include MMRV vaccine and older age at time of vaccination, along with prior fever and seizures and generally being prone to fevers. Even after accounting for general individual and familial susceptibility to fever, fever due to measles vaccine specifically clustered in families, suggesting that some fevers after measles vaccines are related to genetic factors. This study suggests an important link between population health (surveillance of a large population for vaccine adverse events) and personalized medicine (possible genetic basis for fever after measles vaccine). Future work will be needed to further define this possible relationship of genetics and vaccine-associated fever. Challenges included designing ways to account for how different families respond to fever in their children (i.e, seeking medical care or not), and separating out susceptibility to vaccine-associated fever from general susceptibility to fever. We did this by adjusting the analyses for familial tendency to seek care for fever, individual tendency to have fever, and the tendency of being fever-prone (in general) to run in families.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.